Company Overview: Spotlight Innovation

Industry News

27 Sep

Spotlight Innovation Forms Corporate Partnership with University of Iowa Athletics to Promote New Chronic Pain Relief Product “Venodol”

URBANDALE, IA–(Marketwired – Sep 27, 2017) – Spotlight Innovation Inc. ( OTCQB : STLT ) today announced that it has formed a corporate partnership with University of Iowa Athletics that will provide ongoing radio and digital media visibility for the Venodol brand and for Venodol Roll-on to Iowa Hawkeyes Football, Men’s Basketball and Wrestling fans....

Read more

16 Aug

Spotlight Innovation Enters into Sponsored Research Agreement with Indiana University to Develop New Therapies for Spinal Muscular Atrophy

URBANDALE, Iowa, Aug. 16, 2017 /PRNewswire/ — Spotlight Innovation Inc. (STLT) today announced that the Company has entered into a Sponsored Research Agreement with Indiana University to support research directed by Elliot Androphy, M.D., aimed at developing safe and effective drugs to treat patients with spinal muscular atrophy (SMA). Dr. Androphy is a member of Spotlight...

Read more

7 Aug

New Chronic Pain Relief Product “Venodol” Now Available for Pre-order at Venodol.com

Venodol™ is a Non-opioid, Non-addictive Over-the-Counter Alternative to Opioid and Steroidal Analgesics URBANDALE, Iowa, Aug. 7, 2017 /PRNewswire/ — Spotlight Innovation Inc. (STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that its subsidiary Caretta Therapeutics’ new over-the-counter chronic pain relief product, Venodol roll-on, is now available for pre-order in...

Read more

11 Jul

Spotlight Innovation Subsidiary Caretta Therapeutics Engages Public Relations Firm TransMedia Group

TransMedia Group to Provide Public Relations Support for Venodol, a New Over-the-counter, Non-addictive Analgesic for the Treatment of Chronic Pain URBANDALE, Iowa, July 11, 2017 /PRNewswire/ — Spotlight Innovation Inc. (STLT) today announced that its subsidiary Caretta Therapeutics, LLC, has engaged TransMedia Group to provide public relations support for Venodol,...

Read more

26 Jul

Spotlight Innovation

Spotlight Innovation Inc. identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. To find and evaluate unique opportunities, we leverage our extensive relationships with leading scientists, academic institutions and other sources. We provide value-added capability...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address